Author

Thomas Kraus

Icahn School of Medicine at Mount SinaiPrimary ORCID profile (0000-0001-9747-3776 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Thomas KrausiD1 paper · RWTH Aachen University

Biology Disciplines

Click to filter author papers

Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:development & morphogenesis· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Christopher B. BuckiD· 1 shared Diana V. PastranaiD· 1 shared Domenico TortorellaiD· 1 shared Emma B. Barrall· 1 shared Glaucia C. FurtadoiD· 1 shared Huabao Xiong· 1 shared J. Andrew DutyiD· 1 shared Jeremiah J. FaithiD· 1 shared

Activity by Year

2018-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

Christopher B. BuckORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Broadly neutralizing human monoclonal antibodies against BK polyomavirus genotypes

J. Andrew Duty, Thomas Kraus, Madhu Kumar, Nicolo A Tortorella, Tajudeen O. Jimoh, Emma B. Barrall, Diana V. Pastrana, Christopher B. Buck, T. M. MORAN, Domenico Tortorella

This study identifies broadly neutralizing human monoclonal antibodies against BK polyomavirus genotypes I-IV, which could be developed into therapeutics for BKV-related diseases.

Journal of General Virology · Dec 22, 2025Peer-reviewedMicrobiology

Interleukin 22 mediates interleukin 23-induced pathology in newborn mice by disrupting the function of pancreatic and intestinal cells

Glaucia C. Furtado, Lili Chen, Valentina Strohmeier, Zhengxiang He, Madhura Deshpande, Scott K. Durum, Thomas M. Moran, Thomas Kraus, Huabao Xiong, Jeremiah J. Faith, Sergio A. Lira

This study shows that IL-23-induced pathology in newborn mice is mediated by IL-22, which disrupts pancreatic and intestinal cell function, leading to malabsorption and early death.

bioRxiv · Jul 2, 2018 · PreprintImmunology